Cargando…
Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study
BACKGROUND: Angiosarcomas are rare malignant tumors of vascular origin that represent a genuine therapeutic challenge. Recently, the combination of metronomic chemotherapy and drug repositioning has been proposed as an attractive alternative for cancer patients living in developing countries. METHOD...
Autores principales: | Pasquier, Eddy, André, Nicolas, Street, Janine, Chougule, Anuradha, Rekhi, Bharat, Ghosh, Jaya, Philip, Deepa S.J., Meurer, Marie, MacKenzie, Karen L., Kavallaris, Maria, Banavali, Shripad D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856748/ https://www.ncbi.nlm.nih.gov/pubmed/27211551 http://dx.doi.org/10.1016/j.ebiom.2016.02.026 |
Ejemplares similares
-
Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma
por: Banavali, Shripad, et al.
Publicado: (2015) -
Can metronomic maintenance with weekly vinblastine prevent early relapse/progression after bevacizumab–irinotecan in children with low‐grade glioma?
por: Heng, Marie Amélie, et al.
Publicado: (2016) -
Response assessment in metronomic chemotherapy: RECIST or PERCIST?
por: Agrawal, Archi, et al.
Publicado: (2014) -
Metronomics: Intrinsic Anakoinosis Modulator?
por: Nicolas, André, et al.
Publicado: (2018) -
Metronomic Chemotherapy for Children in Low- and Middle-Income Countries: Survey of Current Practices and Opinions of Pediatric Oncologists
por: Revon-Rivière, Gabriel, et al.
Publicado: (2019)